4//SEC Filing
Paulson Richard A. 4
Accession 0000950170-25-065884
CIK 0001503802other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 5:03 PM ET
Size
4.8 KB
Accession
0000950170-25-065884
Insider Transaction Report
Form 4
Paulson Richard A.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-05-06$7.12/sh−236$1,680→ 82,503 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001804460
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 5:03 PM ET
- Size
- 4.8 KB